Il trading comporta dei rischi
Gli investimenti comportano dei rischi e non sono adatti a tutti gli investitori. I CFD sono strumenti complessi e comportano un rischio elevato di perdere rapidamente denaro a causa della leva finanziaria.
Il trading comporta dei rischi
Gli investimenti comportano dei rischi e non sono adatti a tutti gli investitori. I CFD sono strumenti complessi e comportano un rischio elevato di perdere rapidamente denaro a causa della leva finanziaria.
GE HealthCare Technologies
Chiusa
SettoreSettore sanitario
72.95 1.33
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
72.06
Massimo
73.33
Entrata | -88M 500M |
|---|---|
Vendite | 230M 5B |
P/E Media del settore | 14.3 34.393 |
EPS | 1.06 |
Rendimento da dividendi | 0.14 |
Margine di Profitto | 9.986 |
Dipendenti | 53,000 |
EBITDA | -285M 654M |
Raccomandazioni | Fortemente da comprare |
|---|---|
Previsioni per 12 mesi | +18.06% upside |
Rendimento da dividendi Media del settore | 0.14% 2.54% |
|---|---|
Utili prossimi | 29 ott 2025 |
Prossima data del Dividendo | 15 ago 2025 |
Capitalizzazione di Mercato | -3.3B 32B |
|---|---|
Apertura precedente | 71.62 |
Chiusura precedente | 72.95 |
Notizie sul Sentiment di mercato
By Acuity
11%
89%
9 / 374 Classifica in Healthcare
GE HealthCare Technologies Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Notizie correlate
Confronto tra pari
Modifica del prezzo
GE HealthCare Technologies Previsione
Obiettivo di Prezzo
By TipRanks
18.06% in crescita
Previsioni per 12 mesi
Media 85 USD 18.06%
Alto 93 USD
Basso 74 USD
Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per GE HealthCare Technologies - Dist negli ultimi 3 mesi.
Sentiment
By Acuity
9 / 374 Classifica in Settore sanitario
Notizie sul Sentiment di mercato
Prove rialziste molto forti
Volatilità
Sotto la media
Volume delle notizie (RCV)
Sopra la media
Notizie finanziarie
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$
Chi Siamo GE HealthCare Technologies
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
